Current Assets Changement Date
Agilent USD 4.34B 152M 2023-12
Align Technology USD 2.45B 255.19M 2023-12
Bio Techne USD 590.64M 837K 2023-12
BioMarin Pharmaceutical USD 2.96B 780K 2023-12
Bristol-Myers Squibb USD 27.63B 442M 2023-09
Bruker USD 2.16B 135.6M 2023-12
Catalent USD 2.57B 44M 2023-12
Charles River Laboratories USD 1.61B 164.34M 2023-12
Danaher USD 13.94B 7.27B 2023-12
Dentsply International USD 1.97B 60M 2023-12
Exact Sciences USD 1.19B 46.18M 2023-12
General Electric USD 59.8B 3.36B 2023-12
Henry Schein USD 4.49B 375M 2023-12
Illumina USD 2.61B 103M 2023-12
IQVIA Holdings USD 5.6B 388M 2023-12
Mettler Toledo International USD 1.23B 33.29M 2023-12
Myriad Genetics USD 313.6M 48.2M 2023-12
OraSure Technologies USD 356.46M 14.9M 2023-09
Pacific Biosciences Of California USD 882M 53.56M 2023-09
Patterson Companies USD 1.83B 41.89M 2023-12
Peregrine Pharmaceuticals USD 104.2M 5.89M 2023-09
Pfizer USD 74.01B 665M 2023-09
Repligen USD 978.46M 20.13M 2023-09
Revvity USD 3B 87.85M 2023-12
Standard Biotools USD 170.74M 12.33M 2023-09
Thermo Fisher Scientific USD 24.59B 1.5B 2023-12
Waters USD 1.63B 46.66M 2023-09
West Pharmaceutical Services USD 1.97B 98.1M 2023-09



Repligen Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.